IP Verse

Alexion Pharmaceuticals vs. Amgen Technology Ireland Unlimited - UPC_CFI_124/2024

The UPC Case UPC_CFI_124/2024 was filed on 19 Mar, 2024 by the plaintiff Alexion Pharmaceuticals against the defendant Amgen Technology Ireland Unlimited.

Case Details

    Case Number:

    UPC_CFI_124/2024

    Patent Number:

    EP3167888

    Filing Date:

    19 Mar, 2024

    Proceeding Type:

    Provisionalmeasures

    Case Phase:

    Case Closed

    Plaintiffs:

    • Alexion Pharmaceuticals

    Plaintiff Representatives:

    • Elena HENNECKE

    Defendants:

    • Amgen Technology Ireland Unlimited

    Defendant Representatives:

    • Tilman MUELLER-STOY

    Judges:

    • Alima Zana
    • Rudi Goedeweeck
    • Sabine Klepsch
    • Stefan Schilling

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

DateTitleLink
Sep 18, 2025Comments-
Sep 10, 2025Receipt-
Sep 10, 2025Outcome Of The Order-
Sep 10, 2025Deadline Extension
Sep 9, 2025Deadline Extension Request-
Sep 9, 2025262.2 Application-
Sep 4, 2025Anonymisierte Version-
Aug 26, 2025Template Order-
Aug 26, 2025Anhoerung-
Aug 25, 2025Outcome Of The Order-
Aug 25, 2025Order With Grounds
Aug 20, 2025Receipt-
Aug 20, 202520250820 Application For Rectification Amgen En Signiert-
Aug 19, 2025Second Instance Application For Cost Decision Amgen Signed Confidential-
Aug 19, 2025Request 9 1 Rop Costs Rehearing Amgen 33361 2025 35088 2025 Signed-
Aug 19, 2025Request 9 1 Rop Costs First Instance Amgen 43687 2025 35086 2025 Signed-
Aug 19, 2025Request 9 1 Rop Costs Appeal Proceedings Amgen 3053 2025 35087 2025 Signed-
Aug 19, 2025Rehearing Application For Cost Decision Amgen Signed Confidential-
Aug 19, 2025First Instance Reply Of Amgen 43687 2024 Signed Confidential-
Aug 19, 2025First Instance Application For Cost Decision Amgen Signed Confidential-
Aug 19, 2025Comments On Application For Rehearing Costs-
Aug 19, 2025Application 262 2 Rop Costs Rehearing Amgen 33361 2025 Signed-
Aug 19, 2025Application 262 2 Rop Costs First Instance Amgen 43687 2024 Signed-
Aug 19, 2025Application 262 2 Rop Costs Appeal Proceedings Amgen 3053 2025 Signed-
Aug 5, 2025Outcome Of The Order-
Aug 5, 2025Order With Grounds-
Aug 5, 2025Anhoerung-
Aug 5, 2025262A-
Aug 4, 2025Comments-
Jul 28, 2025Anhoerung-
Jul 22, 2025Receipt-
Jul 21, 2025Confidentiality Request Re Application Cost Decision Rehearing En-
Jul 21, 2025Application Cost Decision Rehearing Confidential En-
Sep 30, 2024Outcome Of The Order-
Sep 30, 2024Confirmation Of Appointment Oral Hearing Recording
Sep 26, 2024Receipt-
Sep 25, 2024Request To The Registrar For The Recording Of The Oral Hearing To Be Made Available-
Jul 17, 2024Order With Grounds (Ord 38132 2024)-
Jun 26, 2024Recording-
Jun 26, 2024Procedural Order
Jun 26, 2024Measures Decisionoutcome Notification-
Jun 25, 2024Summons-
Jun 25, 2024Closing Written Proceedings
Jun 18, 2024Closing Workflow
Jun 14, 2024Vorlage Skerra-
Jun 14, 2024Rejoinder Of Amgen Confidential En Signed-
Jun 14, 2024Exhibit Fbd 38A-
Jun 14, 2024Exhibit Bp29 Confidential-
Jun 14, 2024Exhibit Bp28-
Jun 14, 2024Exhibit Bp27-
Jun 14, 2024Exhibit Bp26-
Jun 14, 2024Exhibit Bp25-
Jun 14, 2024Exhibit Bp24-
Jun 14, 2024Exhibit Bp23-
Jun 14, 2024Exhibit Bp22-
Jun 14, 2024Exhibit Bp21-
Jun 14, 2024Exhibit Bp20-
Jun 14, 2024Exhibit Bp19-
Jun 14, 2024Exhibit Bp18-
Jun 14, 2024Exhibit Bp17-
Jun 14, 2024Comments-
May 28, 2024Receipt-
May 28, 2024Outcome Of The Order-
May 28, 2024Deadline Amgen
May 27, 2024Application/Submission-
May 24, 2024Receipt-
May 24, 2024R 262 Application-
May 24, 2024Part I Of The Reply-
May 24, 2024Part Ii Of The Reply-
May 24, 2024Outcome Of The Order-
May 24, 2024Exhibit Fbd A 2-
May 24, 2024Exhibit Fbd A 1-
May 24, 2024Exhibit Fbd 67-
May 24, 2024Exhibit Fbd 66-
May 24, 2024Exhibit Fbd 65-
May 24, 2024Exhibit Fbd 64-
May 24, 2024Exhibit Fbd 63-
May 24, 2024Exhibit Fbd 62-
May 24, 2024Exhibit Fbd 61-
May 24, 2024Exhibit Fbd 60-
May 24, 2024Exhibit Fbd 59-
May 24, 2024Exhibit Fbd 58-
May 24, 2024Exhibit Fbd 57-
May 24, 2024Exhibit Fbd 56-
May 24, 2024Exhibit Fbd 55-
May 24, 2024Exhibit Fbd 54-
May 24, 2024Exhibit Fbd 53-
May 24, 2024Exhibit Fbd 52-
May 24, 2024Exhibit Fbd 51-
May 24, 2024Exhibit Fbd 50-
May 24, 2024Exhibit Fbd 49-
May 24, 2024Exhibit Fbd 48-
May 24, 2024Exhibit Fbd 47-
May 24, 2024Exhibit Fbd 46-
May 24, 2024Exhibit Fbd 45-
May 24, 2024Exhibit Fbd 44-
May 24, 2024Exhibit Fbd 43-
May 24, 2024Exhibit Fbd 42-
May 24, 2024Exhibit Fbd 41-
May 24, 2024Exhibit Fbd 40-
May 24, 2024Exhibit Fbd 39-
May 24, 2024Exhibit Fbd 38-
May 24, 2024Exhibit Fbd 37-
May 24, 2024Exhibit Fbd 36-
May 24, 2024Exhibit Fbd 35-
May 24, 2024Duplik Defendant-
May 24, 2024Closing Workflow
May 16, 2024Rule 9.3 Extension Request-
May 16, 2024Receipt-
May 16, 2024Outcome Of The Order-
May 16, 2024Frist
May 16, 2024Anlage Fbd Fv 2-
May 16, 2024Anlage Fbd Fv 1-
May 7, 2024Outcome Of The Order-
May 7, 2024Frist Applicant
May 3, 2024Summon To Oral Hearing-
May 2, 2024Receipt-
Apr 30, 2024Objection Amgen Dd April 30 2024 Confidential En Signed-
Apr 30, 2024Exhibit Bp16 Amgen En-
Apr 30, 2024Exhibit Bp15 Amgen En-
Apr 30, 2024Exhibit Bp14 Amgen En-
Apr 30, 2024Exhibit Bp13 Amgen En-
Apr 30, 2024Exhibit Bp12 Amgen En-
Apr 30, 2024Exhibit Bp11 Amgen File Wrapper Estoppel En-
Apr 30, 2024Exhibit Bp10E Amgen Confidential Nl-
Apr 30, 2024Exhibit Bp10D Amgen Confidential En-
Apr 30, 2024Exhibit Bp10C Amgen Confidential En-
Apr 30, 2024Exhibit Bp10B Amgen Confidential En-
Apr 30, 2024Exhibit Bp10 Amgen Related Proceedings Confidential En-
Apr 30, 2024Exhibit Bp10A Amgen Confidential De-
Apr 30, 2024Exhibit Bp09P Amgen En-
Apr 30, 2024Exhibit Bp09O Amgen En-
Apr 30, 2024Exhibit Bp09N Amgen En-
Apr 30, 2024Exhibit Bp09M Amgen En-
Apr 30, 2024Exhibit Bp09L Amgen En-
Apr 30, 2024Exhibit Bp09K Amgen En-
Apr 30, 2024Exhibit Bp09J Amgen En-
Apr 30, 2024Exhibit Bp09I Amgen En-
Apr 30, 2024Exhibit Bp09H Amgen En-
Apr 30, 2024Exhibit Bp09G Amgen En-
Apr 30, 2024Exhibit Bp09F Amgen En-
Apr 30, 2024Exhibit Bp09E Amgen En-
Apr 30, 2024Exhibit Bp09D Amgen En-
Apr 30, 2024Exhibit Bp09C Amgen En-
Apr 30, 2024Exhibit Bp09B Amgen En-
Apr 30, 2024Exhibit Bp09 Amgen Grant History En-
Apr 30, 2024Exhibit Bp09A Amgen En-
Apr 30, 2024Exhibit Bp08 Amgen Table Grant Procedures En-
Apr 30, 2024Exhibit Bp07 Amgen En-
Apr 30, 2024Exhibit Bp06 Amgen En-
Apr 30, 2024Exhibit Bp05 Amgen En-
Apr 30, 2024Exhibit Bp04 Amgen Confidential En-
Apr 30, 2024Exhibit Bp03 Amgen Technical Background En-
Apr 30, 2024Exhibit Bp02 Amgen En-
Apr 30, 2024Exhibit Bp01 Amgen En-
Apr 30, 2024Exhibit Bp00 Amgen En Signed-
Apr 17, 2024Panel Appointment-
Apr 14, 2024Template Order-
Apr 14, 2024Procedural Order-
Apr 9, 2024Receipt-
Apr 9, 2024Notification Of Service-
Apr 9, 2024Mail Service Sweden-
Apr 9, 2024Antrag/Schriftsatz-
Apr 9, 2024Acknowledgement Of Access To Case-
Apr 2, 2024Acknowledgement Of Access To Case-
Mar 28, 2024Service Italy-
Mar 28, 2024Service Italien-
Mar 28, 2024Service French-
Mar 28, 2024Service Frankreich-
Mar 28, 2024Notification Of Service-
Mar 27, 2024Service Portugal-
Mar 27, 2024Service Munich-
Mar 27, 2024Service Belgium-
Mar 27, 2024Notification Of Service-
Mar 26, 2024Service Slovenia-
Mar 26, 2024Service Ireland-
Mar 26, 2024Service Austria-
Mar 26, 2024Panel Appointment-
Mar 26, 2024Notification Of Service-
Mar 20, 2024Receipt-
Mar 20, 2024Letter For Service-
Mar 20, 2024Invitation To Lodge
Mar 19, 2024Set Of Exhibits Fbd 5B-
Mar 19, 2024Set Of Exhibits Fbd 5A-
Mar 19, 2024Panel Appointment-
Mar 19, 2024Formal Checks Notification Of Positive Outcome-
Mar 19, 2024Exhibit Fbd 9-
Mar 19, 2024Exhibit Fbd 8-
Mar 19, 2024Exhibit Fbd 7-
Mar 19, 2024Exhibit Fbd 6-
Mar 19, 2024Exhibit Fbd 4-
Mar 19, 2024Exhibit Fbd 34-
Mar 19, 2024Exhibit Fbd 33A-
Mar 19, 2024Exhibit Fbd 33-
Mar 19, 2024Exhibit Fbd 32A-
Mar 19, 2024Exhibit Fbd 32-
Mar 19, 2024Exhibit Fbd 31-
Mar 19, 2024Exhibit Fbd 30-
Mar 19, 2024Exhibit Fbd 3-
Mar 19, 2024Exhibit Fbd 29-
Mar 19, 2024Exhibit Fbd 28-
Mar 19, 2024Exhibit Fbd 27-
Mar 19, 2024Exhibit Fbd 26-
Mar 19, 2024Exhibit Fbd 25-
Mar 19, 2024Exhibit Fbd 24-
Mar 19, 2024Exhibit Fbd 23-
Mar 19, 2024Exhibit Fbd 22-
Mar 19, 2024Exhibit Fbd 21-
Mar 19, 2024Exhibit Fbd 20-
Mar 19, 2024Exhibit Fbd 19-
Mar 19, 2024Exhibit Fbd 18A-
Mar 19, 2024Exhibit Fbd 18-
Mar 19, 2024Exhibit Fbd 17C-
Mar 19, 2024Exhibit Fbd 17B-
Mar 19, 2024Exhibit Fbd 17A-
Mar 19, 2024Exhibit Fbd 16-
Mar 19, 2024Exhibit Fbd 15-
Mar 19, 2024Exhibit Fbd 14-
Mar 19, 2024Exhibit Fbd 13-
Mar 19, 2024Exhibit Fbd 12-
Mar 19, 2024Exhibit Fbd 11-
Mar 19, 2024Exhibit Fbd 10-
Mar 19, 2024Exhibit Fbd 1-
Mar 19, 2024Exhibit Fbd 0-
Mar 19, 2024Confidential Exhibit Fbd 2-
Mar 19, 2024Application To Request Confidentiality From The Public-
Mar 19, 2024Application For Provisional Measures-
Mar 19, 2024Application For Measures Receipt-
Mar 19, 2024Application For Measures Acknowledgement-
Sep 18, 2025Comments-
Sep 10, 2025Receipt-
Sep 10, 2025Outcome Of The Order-
Sep 10, 2025Deadline Extension
Sep 9, 2025Deadline Extension Request-
Sep 9, 2025262.2 Application-
Sep 4, 2025Anonymisierte Version-
Aug 26, 2025Template Order-
Aug 26, 2025Anhoerung-
Aug 25, 2025Outcome Of The Order-
Aug 25, 2025Order With Grounds
Aug 20, 2025Receipt-
Aug 20, 202520250820 Application For Rectification Amgen En Signiert-
Aug 19, 2025Second Instance Application For Cost Decision Amgen Signed Confidential-
Aug 19, 2025Request 9 1 Rop Costs Rehearing Amgen 33361 2025 35088 2025 Signed-
Aug 19, 2025Request 9 1 Rop Costs First Instance Amgen 43687 2025 35086 2025 Signed-
Aug 19, 2025Request 9 1 Rop Costs Appeal Proceedings Amgen 3053 2025 35087 2025 Signed-
Aug 19, 2025Rehearing Application For Cost Decision Amgen Signed Confidential-
Aug 19, 2025First Instance Reply Of Amgen 43687 2024 Signed Confidential-
Aug 19, 2025First Instance Application For Cost Decision Amgen Signed Confidential-
Aug 19, 2025Comments On Application For Rehearing Costs-
Aug 19, 2025Application 262 2 Rop Costs Rehearing Amgen 33361 2025 Signed-
Aug 19, 2025Application 262 2 Rop Costs First Instance Amgen 43687 2024 Signed-
Aug 19, 2025Application 262 2 Rop Costs Appeal Proceedings Amgen 3053 2025 Signed-
Aug 5, 2025Outcome Of The Order-
Aug 5, 2025Order With Grounds-
Aug 5, 2025Anhoerung-
Aug 5, 2025262A-
Aug 4, 2025Comments-
Jul 28, 2025Anhoerung-
Jul 22, 2025Receipt-
Jul 21, 2025Confidentiality Request Re Application Cost Decision Rehearing En-
Jul 21, 2025Application Cost Decision Rehearing Confidential En-
Sep 30, 2024Outcome Of The Order-
Sep 30, 2024Confirmation Of Appointment Oral Hearing Recording
Sep 26, 2024Receipt-
Sep 25, 2024Request To The Registrar For The Recording Of The Oral Hearing To Be Made Available-
Jul 17, 2024Order With Grounds (Ord 38132 2024)-
Jun 26, 2024Recording-
Jun 26, 2024Procedural Order
Jun 26, 2024Measures Decisionoutcome Notification-
Jun 25, 2024Summons-
Jun 25, 2024Closing Written Proceedings
Jun 18, 2024Closing Workflow
Jun 14, 2024Vorlage Skerra-
Jun 14, 2024Rejoinder Of Amgen Confidential En Signed-
Jun 14, 2024Exhibit Fbd 38A-
Jun 14, 2024Exhibit Bp29 Confidential-
Jun 14, 2024Exhibit Bp28-
Jun 14, 2024Exhibit Bp27-
Jun 14, 2024Exhibit Bp26-
Jun 14, 2024Exhibit Bp25-
Jun 14, 2024Exhibit Bp24-
Jun 14, 2024Exhibit Bp23-
Jun 14, 2024Exhibit Bp22-
Jun 14, 2024Exhibit Bp21-
Jun 14, 2024Exhibit Bp20-
Jun 14, 2024Exhibit Bp19-
Jun 14, 2024Exhibit Bp18-
Jun 14, 2024Exhibit Bp17-
Jun 14, 2024Comments-
May 28, 2024Receipt-
May 28, 2024Outcome Of The Order-
May 28, 2024Deadline Amgen
May 27, 2024Application/Submission-
May 24, 2024Receipt-
May 24, 2024R 262 Application-
May 24, 2024Part I Of The Reply-
May 24, 2024Part Ii Of The Reply-
May 24, 2024Outcome Of The Order-
May 24, 2024Exhibit Fbd A 2-
May 24, 2024Exhibit Fbd A 1-
May 24, 2024Exhibit Fbd 67-
May 24, 2024Exhibit Fbd 66-
May 24, 2024Exhibit Fbd 65-
May 24, 2024Exhibit Fbd 64-
May 24, 2024Exhibit Fbd 63-
May 24, 2024Exhibit Fbd 62-
May 24, 2024Exhibit Fbd 61-
May 24, 2024Exhibit Fbd 60-
May 24, 2024Exhibit Fbd 59-
May 24, 2024Exhibit Fbd 58-
May 24, 2024Exhibit Fbd 57-
May 24, 2024Exhibit Fbd 56-
May 24, 2024Exhibit Fbd 55-
May 24, 2024Exhibit Fbd 54-
May 24, 2024Exhibit Fbd 53-
May 24, 2024Exhibit Fbd 52-
May 24, 2024Exhibit Fbd 51-
May 24, 2024Exhibit Fbd 50-
May 24, 2024Exhibit Fbd 49-
May 24, 2024Exhibit Fbd 48-
May 24, 2024Exhibit Fbd 47-
May 24, 2024Exhibit Fbd 46-
May 24, 2024Exhibit Fbd 45-
May 24, 2024Exhibit Fbd 44-
May 24, 2024Exhibit Fbd 43-
May 24, 2024Exhibit Fbd 42-
May 24, 2024Exhibit Fbd 41-
May 24, 2024Exhibit Fbd 40-
May 24, 2024Exhibit Fbd 39-
May 24, 2024Exhibit Fbd 38-
May 24, 2024Exhibit Fbd 37-
May 24, 2024Exhibit Fbd 36-
May 24, 2024Exhibit Fbd 35-
May 24, 2024Duplik Defendant-
May 24, 2024Closing Workflow
May 16, 2024Rule 9.3 Extension Request-
May 16, 2024Receipt-
May 16, 2024Outcome Of The Order-
May 16, 2024Frist
May 16, 2024Anlage Fbd Fv 2-
May 16, 2024Anlage Fbd Fv 1-
May 7, 2024Outcome Of The Order-
May 7, 2024Frist Applicant
May 3, 2024Summon To Oral Hearing-
May 2, 2024Receipt-
Apr 30, 2024Objection Amgen Dd April 30 2024 Confidential En Signed-
Apr 30, 2024Exhibit Bp16 Amgen En-
Apr 30, 2024Exhibit Bp15 Amgen En-
Apr 30, 2024Exhibit Bp14 Amgen En-
Apr 30, 2024Exhibit Bp13 Amgen En-
Apr 30, 2024Exhibit Bp12 Amgen En-
Apr 30, 2024Exhibit Bp11 Amgen File Wrapper Estoppel En-
Apr 30, 2024Exhibit Bp10E Amgen Confidential Nl-
Apr 30, 2024Exhibit Bp10D Amgen Confidential En-
Apr 30, 2024Exhibit Bp10C Amgen Confidential En-
Apr 30, 2024Exhibit Bp10B Amgen Confidential En-
Apr 30, 2024Exhibit Bp10 Amgen Related Proceedings Confidential En-
Apr 30, 2024Exhibit Bp10A Amgen Confidential De-
Apr 30, 2024Exhibit Bp09P Amgen En-
Apr 30, 2024Exhibit Bp09O Amgen En-
Apr 30, 2024Exhibit Bp09N Amgen En-
Apr 30, 2024Exhibit Bp09M Amgen En-
Apr 30, 2024Exhibit Bp09L Amgen En-
Apr 30, 2024Exhibit Bp09K Amgen En-
Apr 30, 2024Exhibit Bp09J Amgen En-
Apr 30, 2024Exhibit Bp09I Amgen En-
Apr 30, 2024Exhibit Bp09H Amgen En-
Apr 30, 2024Exhibit Bp09G Amgen En-
Apr 30, 2024Exhibit Bp09F Amgen En-
Apr 30, 2024Exhibit Bp09E Amgen En-
Apr 30, 2024Exhibit Bp09D Amgen En-
Apr 30, 2024Exhibit Bp09C Amgen En-
Apr 30, 2024Exhibit Bp09B Amgen En-
Apr 30, 2024Exhibit Bp09 Amgen Grant History En-
Apr 30, 2024Exhibit Bp09A Amgen En-
Apr 30, 2024Exhibit Bp08 Amgen Table Grant Procedures En-
Apr 30, 2024Exhibit Bp07 Amgen En-
Apr 30, 2024Exhibit Bp06 Amgen En-
Apr 30, 2024Exhibit Bp05 Amgen En-
Apr 30, 2024Exhibit Bp04 Amgen Confidential En-
Apr 30, 2024Exhibit Bp03 Amgen Technical Background En-
Apr 30, 2024Exhibit Bp02 Amgen En-
Apr 30, 2024Exhibit Bp01 Amgen En-
Apr 30, 2024Exhibit Bp00 Amgen En Signed-
Apr 17, 2024Panel Appointment-
Apr 14, 2024Template Order-
Apr 14, 2024Procedural Order-
Apr 9, 2024Receipt-
Apr 9, 2024Notification Of Service-
Apr 9, 2024Mail Service Sweden-
Apr 9, 2024Antrag/Schriftsatz-
Apr 9, 2024Acknowledgement Of Access To Case-
Apr 2, 2024Acknowledgement Of Access To Case-
Mar 28, 2024Service Italy-
Mar 28, 2024Service Italien-
Mar 28, 2024Service French-
Mar 28, 2024Service Frankreich-
Mar 28, 2024Notification Of Service-
Mar 27, 2024Service Portugal-
Mar 27, 2024Service Munich-
Mar 27, 2024Service Belgium-
Mar 27, 2024Notification Of Service-
Mar 26, 2024Service Slovenia-
Mar 26, 2024Service Ireland-
Mar 26, 2024Service Austria-
Mar 26, 2024Panel Appointment-
Mar 26, 2024Notification Of Service-
Mar 20, 2024Receipt-
Mar 20, 2024Letter For Service-
Mar 20, 2024Invitation To Lodge
Mar 19, 2024Set Of Exhibits Fbd 5B-
Mar 19, 2024Set Of Exhibits Fbd 5A-
Mar 19, 2024Panel Appointment-
Mar 19, 2024Formal Checks Notification Of Positive Outcome-
Mar 19, 2024Exhibit Fbd 9-
Mar 19, 2024Exhibit Fbd 8-
Mar 19, 2024Exhibit Fbd 7-
Mar 19, 2024Exhibit Fbd 6-
Mar 19, 2024Exhibit Fbd 4-
Mar 19, 2024Exhibit Fbd 34-
Mar 19, 2024Exhibit Fbd 33A-
Mar 19, 2024Exhibit Fbd 33-
Mar 19, 2024Exhibit Fbd 32A-
Mar 19, 2024Exhibit Fbd 32-
Mar 19, 2024Exhibit Fbd 31-
Mar 19, 2024Exhibit Fbd 30-
Mar 19, 2024Exhibit Fbd 3-
Mar 19, 2024Exhibit Fbd 29-
Mar 19, 2024Exhibit Fbd 28-
Mar 19, 2024Exhibit Fbd 27-
Mar 19, 2024Exhibit Fbd 26-
Mar 19, 2024Exhibit Fbd 25-
Mar 19, 2024Exhibit Fbd 24-
Mar 19, 2024Exhibit Fbd 23-
Mar 19, 2024Exhibit Fbd 22-
Mar 19, 2024Exhibit Fbd 21-
Mar 19, 2024Exhibit Fbd 20-
Mar 19, 2024Exhibit Fbd 19-
Mar 19, 2024Exhibit Fbd 18A-
Mar 19, 2024Exhibit Fbd 18-
Mar 19, 2024Exhibit Fbd 17C-
Mar 19, 2024Exhibit Fbd 17B-
Mar 19, 2024Exhibit Fbd 17A-
Mar 19, 2024Exhibit Fbd 16-
Mar 19, 2024Exhibit Fbd 15-
Mar 19, 2024Exhibit Fbd 14-
Mar 19, 2024Exhibit Fbd 13-
Mar 19, 2024Exhibit Fbd 12-
Mar 19, 2024Exhibit Fbd 11-
Mar 19, 2024Exhibit Fbd 10-
Mar 19, 2024Exhibit Fbd 1-
Mar 19, 2024Exhibit Fbd 0-
Mar 19, 2024Confidential Exhibit Fbd 2-
Mar 19, 2024Application To Request Confidentiality From The Public-
Mar 19, 2024Application For Provisional Measures-
Mar 19, 2024Application For Measures Receipt-
Mar 19, 2024Application For Measures Acknowledgement-
Sep 18, 2025Comments-
Sep 10, 2025Receipt-
Sep 10, 2025Outcome Of The Order-
Sep 10, 2025Deadline Extension
Sep 9, 2025Deadline Extension Request-
Sep 9, 2025262.2 Application-
Sep 4, 2025Anonymisierte Version-
Aug 26, 2025Template Order-
Aug 26, 2025Anhoerung-
Aug 25, 2025Outcome Of The Order-
Aug 25, 2025Order With Grounds
Aug 20, 2025Receipt-
Aug 20, 202520250820 Application For Rectification Amgen En Signiert-
Aug 19, 2025Second Instance Application For Cost Decision Amgen Signed Confidential-
Aug 19, 2025Request 9 1 Rop Costs Rehearing Amgen 33361 2025 35088 2025 Signed-
Aug 19, 2025Request 9 1 Rop Costs First Instance Amgen 43687 2025 35086 2025 Signed-
Aug 19, 2025Request 9 1 Rop Costs Appeal Proceedings Amgen 3053 2025 35087 2025 Signed-
Aug 19, 2025Rehearing Application For Cost Decision Amgen Signed Confidential-
Aug 19, 2025First Instance Reply Of Amgen 43687 2024 Signed Confidential-
Aug 19, 2025First Instance Application For Cost Decision Amgen Signed Confidential-
Aug 19, 2025Comments On Application For Rehearing Costs-
Aug 19, 2025Application 262 2 Rop Costs Rehearing Amgen 33361 2025 Signed-
Aug 19, 2025Application 262 2 Rop Costs First Instance Amgen 43687 2024 Signed-
Aug 19, 2025Application 262 2 Rop Costs Appeal Proceedings Amgen 3053 2025 Signed-
Aug 5, 2025Outcome Of The Order-
Aug 5, 2025Order With Grounds-
Aug 5, 2025Anhoerung-
Aug 5, 2025262A-
Aug 4, 2025Comments-
Jul 28, 2025Anhoerung-
Jul 22, 2025Receipt-
Jul 21, 2025Confidentiality Request Re Application Cost Decision Rehearing En-
Jul 21, 2025Application Cost Decision Rehearing Confidential En-
Sep 30, 2024Outcome Of The Order-
Sep 30, 2024Confirmation Of Appointment Oral Hearing Recording
Sep 26, 2024Receipt-
Sep 25, 2024Request To The Registrar For The Recording Of The Oral Hearing To Be Made Available-
Jul 17, 2024Order With Grounds (Ord 38132 2024)-
Jun 26, 2024Recording-
Jun 26, 2024Procedural Order
Jun 26, 2024Measures Decisionoutcome Notification-
Jun 25, 2024Summons-
Jun 25, 2024Closing Written Proceedings
Jun 18, 2024Closing Workflow
Jun 14, 2024Vorlage Skerra-
Jun 14, 2024Rejoinder Of Amgen Confidential En Signed-
Jun 14, 2024Exhibit Fbd 38A-
Jun 14, 2024Exhibit Bp29 Confidential-
Jun 14, 2024Exhibit Bp28-
Jun 14, 2024Exhibit Bp27-
Jun 14, 2024Exhibit Bp26-
Jun 14, 2024Exhibit Bp25-
Jun 14, 2024Exhibit Bp24-
Jun 14, 2024Exhibit Bp23-
Jun 14, 2024Exhibit Bp22-
Jun 14, 2024Exhibit Bp21-
Jun 14, 2024Exhibit Bp20-
Jun 14, 2024Exhibit Bp19-
Jun 14, 2024Exhibit Bp18-
Jun 14, 2024Exhibit Bp17-
Jun 14, 2024Comments-
May 28, 2024Receipt-
May 28, 2024Outcome Of The Order-
May 28, 2024Deadline Amgen
May 27, 2024Application/Submission-
May 24, 2024Receipt-
May 24, 2024R 262 Application-
May 24, 2024Part I Of The Reply-
May 24, 2024Part Ii Of The Reply-
May 24, 2024Outcome Of The Order-
May 24, 2024Exhibit Fbd A 2-
May 24, 2024Exhibit Fbd A 1-
May 24, 2024Exhibit Fbd 67-
May 24, 2024Exhibit Fbd 66-
May 24, 2024Exhibit Fbd 65-
May 24, 2024Exhibit Fbd 64-
May 24, 2024Exhibit Fbd 63-
May 24, 2024Exhibit Fbd 62-
May 24, 2024Exhibit Fbd 61-
May 24, 2024Exhibit Fbd 60-
May 24, 2024Exhibit Fbd 59-
May 24, 2024Exhibit Fbd 58-
May 24, 2024Exhibit Fbd 57-
May 24, 2024Exhibit Fbd 56-
May 24, 2024Exhibit Fbd 55-
May 24, 2024Exhibit Fbd 54-
May 24, 2024Exhibit Fbd 53-
May 24, 2024Exhibit Fbd 52-
May 24, 2024Exhibit Fbd 51-
May 24, 2024Exhibit Fbd 50-
May 24, 2024Exhibit Fbd 49-
May 24, 2024Exhibit Fbd 48-
May 24, 2024Exhibit Fbd 47-
May 24, 2024Exhibit Fbd 46-
May 24, 2024Exhibit Fbd 45-
May 24, 2024Exhibit Fbd 44-
May 24, 2024Exhibit Fbd 43-
May 24, 2024Exhibit Fbd 42-
May 24, 2024Exhibit Fbd 41-
May 24, 2024Exhibit Fbd 40-
May 24, 2024Exhibit Fbd 39-
May 24, 2024Exhibit Fbd 38-
May 24, 2024Exhibit Fbd 37-
May 24, 2024Exhibit Fbd 36-
May 24, 2024Exhibit Fbd 35-
May 24, 2024Duplik Defendant-
May 24, 2024Closing Workflow
May 16, 2024Rule 9.3 Extension Request-
May 16, 2024Receipt-
May 16, 2024Outcome Of The Order-
May 16, 2024Frist
May 16, 2024Anlage Fbd Fv 2-
May 16, 2024Anlage Fbd Fv 1-
May 7, 2024Outcome Of The Order-
May 7, 2024Frist Applicant
May 3, 2024Summon To Oral Hearing-
May 2, 2024Receipt-
Apr 30, 2024Objection Amgen Dd April 30 2024 Confidential En Signed-
Apr 30, 2024Exhibit Bp16 Amgen En-
Apr 30, 2024Exhibit Bp15 Amgen En-
Apr 30, 2024Exhibit Bp14 Amgen En-
Apr 30, 2024Exhibit Bp13 Amgen En-
Apr 30, 2024Exhibit Bp12 Amgen En-
Apr 30, 2024Exhibit Bp11 Amgen File Wrapper Estoppel En-
Apr 30, 2024Exhibit Bp10E Amgen Confidential Nl-
Apr 30, 2024Exhibit Bp10D Amgen Confidential En-
Apr 30, 2024Exhibit Bp10C Amgen Confidential En-
Apr 30, 2024Exhibit Bp10B Amgen Confidential En-
Apr 30, 2024Exhibit Bp10 Amgen Related Proceedings Confidential En-
Apr 30, 2024Exhibit Bp10A Amgen Confidential De-
Apr 30, 2024Exhibit Bp09P Amgen En-
Apr 30, 2024Exhibit Bp09O Amgen En-
Apr 30, 2024Exhibit Bp09N Amgen En-
Apr 30, 2024Exhibit Bp09M Amgen En-
Apr 30, 2024Exhibit Bp09L Amgen En-
Apr 30, 2024Exhibit Bp09K Amgen En-
Apr 30, 2024Exhibit Bp09J Amgen En-
Apr 30, 2024Exhibit Bp09I Amgen En-
Apr 30, 2024Exhibit Bp09H Amgen En-
Apr 30, 2024Exhibit Bp09G Amgen En-
Apr 30, 2024Exhibit Bp09F Amgen En-
Apr 30, 2024Exhibit Bp09E Amgen En-
Apr 30, 2024Exhibit Bp09D Amgen En-
Apr 30, 2024Exhibit Bp09C Amgen En-
Apr 30, 2024Exhibit Bp09B Amgen En-
Apr 30, 2024Exhibit Bp09 Amgen Grant History En-
Apr 30, 2024Exhibit Bp09A Amgen En-
Apr 30, 2024Exhibit Bp08 Amgen Table Grant Procedures En-
Apr 30, 2024Exhibit Bp07 Amgen En-
Apr 30, 2024Exhibit Bp06 Amgen En-
Apr 30, 2024Exhibit Bp05 Amgen En-
Apr 30, 2024Exhibit Bp04 Amgen Confidential En-
Apr 30, 2024Exhibit Bp03 Amgen Technical Background En-
Apr 30, 2024Exhibit Bp02 Amgen En-
Apr 30, 2024Exhibit Bp01 Amgen En-
Apr 30, 2024Exhibit Bp00 Amgen En Signed-
Apr 17, 2024Panel Appointment-
Apr 14, 2024Template Order-
Apr 14, 2024Procedural Order-
Apr 9, 2024Receipt-
Apr 9, 2024Notification Of Service-
Apr 9, 2024Mail Service Sweden-
Apr 9, 2024Antrag/Schriftsatz-
Apr 9, 2024Acknowledgement Of Access To Case-
Apr 2, 2024Acknowledgement Of Access To Case-
Mar 28, 2024Service Italy-
Mar 28, 2024Service Italien-
Mar 28, 2024Service French-
Mar 28, 2024Service Frankreich-
Mar 28, 2024Notification Of Service-
Mar 27, 2024Service Portugal-
Mar 27, 2024Service Munich-
Mar 27, 2024Service Belgium-
Mar 27, 2024Notification Of Service-
Mar 26, 2024Service Slovenia-
Mar 26, 2024Service Ireland-
Mar 26, 2024Service Austria-
Mar 26, 2024Panel Appointment-
Mar 26, 2024Notification Of Service-
Mar 20, 2024Receipt-
Mar 20, 2024Letter For Service-
Mar 20, 2024Invitation To Lodge
Mar 19, 2024Set Of Exhibits Fbd 5B-
Mar 19, 2024Set Of Exhibits Fbd 5A-
Mar 19, 2024Panel Appointment-
Mar 19, 2024Formal Checks Notification Of Positive Outcome-
Mar 19, 2024Exhibit Fbd 9-
Mar 19, 2024Exhibit Fbd 8-
Mar 19, 2024Exhibit Fbd 7-
Mar 19, 2024Exhibit Fbd 6-
Mar 19, 2024Exhibit Fbd 4-
Mar 19, 2024Exhibit Fbd 34-
Mar 19, 2024Exhibit Fbd 33A-
Mar 19, 2024Exhibit Fbd 33-
Mar 19, 2024Exhibit Fbd 32A-
Mar 19, 2024Exhibit Fbd 32-
Mar 19, 2024Exhibit Fbd 31-
Mar 19, 2024Exhibit Fbd 30-
Mar 19, 2024Exhibit Fbd 3-
Mar 19, 2024Exhibit Fbd 29-
Mar 19, 2024Exhibit Fbd 28-
Mar 19, 2024Exhibit Fbd 27-
Mar 19, 2024Exhibit Fbd 26-
Mar 19, 2024Exhibit Fbd 25-
Mar 19, 2024Exhibit Fbd 24-
Mar 19, 2024Exhibit Fbd 23-
Mar 19, 2024Exhibit Fbd 22-
Mar 19, 2024Exhibit Fbd 21-
Mar 19, 2024Exhibit Fbd 20-
Mar 19, 2024Exhibit Fbd 19-
Mar 19, 2024Exhibit Fbd 18A-
Mar 19, 2024Exhibit Fbd 18-
Mar 19, 2024Exhibit Fbd 17C-
Mar 19, 2024Exhibit Fbd 17B-
Mar 19, 2024Exhibit Fbd 17A-
Mar 19, 2024Exhibit Fbd 16-
Mar 19, 2024Exhibit Fbd 15-
Mar 19, 2024Exhibit Fbd 14-
Mar 19, 2024Exhibit Fbd 13-
Mar 19, 2024Exhibit Fbd 12-
Mar 19, 2024Exhibit Fbd 11-
Mar 19, 2024Exhibit Fbd 10-
Mar 19, 2024Exhibit Fbd 1-
Mar 19, 2024Exhibit Fbd 0-
Mar 19, 2024Confidential Exhibit Fbd 2-
Mar 19, 2024Application To Request Confidentiality From The Public-
Mar 19, 2024Application For Provisional Measures-
Mar 19, 2024Application For Measures Receipt-
Mar 19, 2024Application For Measures Acknowledgement-
Sep 18, 2025Comments-
Sep 10, 2025Receipt-
Sep 10, 2025Outcome Of The Order-
Sep 10, 2025Deadline Extension
Sep 9, 2025Deadline Extension Request-
Sep 9, 2025262.2 Application-
Sep 4, 2025Anonymisierte Version-
Aug 26, 2025Template Order-
Aug 26, 2025Anhoerung-
Aug 25, 2025Outcome Of The Order-
Aug 25, 2025Order With Grounds
Aug 20, 2025Receipt-
Aug 20, 202520250820 Application For Rectification Amgen En Signiert-
Aug 19, 2025Second Instance Application For Cost Decision Amgen Signed Confidential-
Aug 19, 2025Request 9 1 Rop Costs Rehearing Amgen 33361 2025 35088 2025 Signed-
Aug 19, 2025Request 9 1 Rop Costs First Instance Amgen 43687 2025 35086 2025 Signed-
Aug 19, 2025Request 9 1 Rop Costs Appeal Proceedings Amgen 3053 2025 35087 2025 Signed-
Aug 19, 2025Rehearing Application For Cost Decision Amgen Signed Confidential-
Aug 19, 2025First Instance Reply Of Amgen 43687 2024 Signed Confidential-
Aug 19, 2025First Instance Application For Cost Decision Amgen Signed Confidential-
Aug 19, 2025Comments On Application For Rehearing Costs-
Aug 19, 2025Application 262 2 Rop Costs Rehearing Amgen 33361 2025 Signed-
Aug 19, 2025Application 262 2 Rop Costs First Instance Amgen 43687 2024 Signed-
Aug 19, 2025Application 262 2 Rop Costs Appeal Proceedings Amgen 3053 2025 Signed-
Aug 5, 2025Outcome Of The Order-
Aug 5, 2025Order With Grounds-
Aug 5, 2025Anhoerung-
Aug 5, 2025262A-
Aug 4, 2025Comments-
Jul 28, 2025Anhoerung-
Jul 22, 2025Receipt-
Jul 21, 2025Confidentiality Request Re Application Cost Decision Rehearing En-
Jul 21, 2025Application Cost Decision Rehearing Confidential En-
Sep 30, 2024Outcome Of The Order-
Sep 30, 2024Confirmation Of Appointment Oral Hearing Recording
Sep 26, 2024Receipt-
Sep 25, 2024Request To The Registrar For The Recording Of The Oral Hearing To Be Made Available-
Jul 17, 2024Order With Grounds (Ord 38132 2024)-
Jun 26, 2024Recording-
Jun 26, 2024Procedural Order
Jun 26, 2024Measures Decisionoutcome Notification-
Jun 25, 2024Summons-
Jun 25, 2024Closing Written Proceedings
Jun 18, 2024Closing Workflow
Jun 14, 2024Vorlage Skerra-
Jun 14, 2024Rejoinder Of Amgen Confidential En Signed-
Jun 14, 2024Exhibit Fbd 38A-
Jun 14, 2024Exhibit Bp29 Confidential-
Jun 14, 2024Exhibit Bp28-
Jun 14, 2024Exhibit Bp27-
Jun 14, 2024Exhibit Bp26-
Jun 14, 2024Exhibit Bp25-
Jun 14, 2024Exhibit Bp24-
Jun 14, 2024Exhibit Bp23-
Jun 14, 2024Exhibit Bp22-
Jun 14, 2024Exhibit Bp21-
Jun 14, 2024Exhibit Bp20-
Jun 14, 2024Exhibit Bp19-
Jun 14, 2024Exhibit Bp18-
Jun 14, 2024Exhibit Bp17-
Jun 14, 2024Comments-
May 28, 2024Receipt-
May 28, 2024Outcome Of The Order-
May 28, 2024Deadline Amgen
May 27, 2024Application/Submission-
May 24, 2024Receipt-
May 24, 2024R 262 Application-
May 24, 2024Part I Of The Reply-
May 24, 2024Part Ii Of The Reply-
May 24, 2024Outcome Of The Order-
May 24, 2024Exhibit Fbd A 2-
May 24, 2024Exhibit Fbd A 1-
May 24, 2024Exhibit Fbd 67-
May 24, 2024Exhibit Fbd 66-
May 24, 2024Exhibit Fbd 65-
May 24, 2024Exhibit Fbd 64-
May 24, 2024Exhibit Fbd 63-
May 24, 2024Exhibit Fbd 62-
May 24, 2024Exhibit Fbd 61-
May 24, 2024Exhibit Fbd 60-
May 24, 2024Exhibit Fbd 59-
May 24, 2024Exhibit Fbd 58-
May 24, 2024Exhibit Fbd 57-
May 24, 2024Exhibit Fbd 56-
May 24, 2024Exhibit Fbd 55-
May 24, 2024Exhibit Fbd 54-
May 24, 2024Exhibit Fbd 53-
May 24, 2024Exhibit Fbd 52-
May 24, 2024Exhibit Fbd 51-
May 24, 2024Exhibit Fbd 50-
May 24, 2024Exhibit Fbd 49-
May 24, 2024Exhibit Fbd 48-
May 24, 2024Exhibit Fbd 47-
May 24, 2024Exhibit Fbd 46-
May 24, 2024Exhibit Fbd 45-
May 24, 2024Exhibit Fbd 44-
May 24, 2024Exhibit Fbd 43-
May 24, 2024Exhibit Fbd 42-
May 24, 2024Exhibit Fbd 41-
May 24, 2024Exhibit Fbd 40-
May 24, 2024Exhibit Fbd 39-
May 24, 2024Exhibit Fbd 38-
May 24, 2024Exhibit Fbd 37-
May 24, 2024Exhibit Fbd 36-
May 24, 2024Exhibit Fbd 35-
May 24, 2024Duplik Defendant-
May 24, 2024Closing Workflow
May 16, 2024Rule 9.3 Extension Request-
May 16, 2024Receipt-
May 16, 2024Outcome Of The Order-
May 16, 2024Frist
May 16, 2024Anlage Fbd Fv 2-
May 16, 2024Anlage Fbd Fv 1-
May 7, 2024Outcome Of The Order-
May 7, 2024Frist Applicant
May 3, 2024Summon To Oral Hearing-
May 2, 2024Receipt-
Apr 30, 2024Objection Amgen Dd April 30 2024 Confidential En Signed-
Apr 30, 2024Exhibit Bp16 Amgen En-
Apr 30, 2024Exhibit Bp15 Amgen En-
Apr 30, 2024Exhibit Bp14 Amgen En-
Apr 30, 2024Exhibit Bp13 Amgen En-
Apr 30, 2024Exhibit Bp12 Amgen En-
Apr 30, 2024Exhibit Bp11 Amgen File Wrapper Estoppel En-
Apr 30, 2024Exhibit Bp10E Amgen Confidential Nl-
Apr 30, 2024Exhibit Bp10D Amgen Confidential En-
Apr 30, 2024Exhibit Bp10C Amgen Confidential En-
Apr 30, 2024Exhibit Bp10B Amgen Confidential En-
Apr 30, 2024Exhibit Bp10 Amgen Related Proceedings Confidential En-
Apr 30, 2024Exhibit Bp10A Amgen Confidential De-
Apr 30, 2024Exhibit Bp09P Amgen En-
Apr 30, 2024Exhibit Bp09O Amgen En-
Apr 30, 2024Exhibit Bp09N Amgen En-
Apr 30, 2024Exhibit Bp09M Amgen En-
Apr 30, 2024Exhibit Bp09L Amgen En-
Apr 30, 2024Exhibit Bp09K Amgen En-
Apr 30, 2024Exhibit Bp09J Amgen En-
Apr 30, 2024Exhibit Bp09I Amgen En-
Apr 30, 2024Exhibit Bp09H Amgen En-
Apr 30, 2024Exhibit Bp09G Amgen En-
Apr 30, 2024Exhibit Bp09F Amgen En-
Apr 30, 2024Exhibit Bp09E Amgen En-
Apr 30, 2024Exhibit Bp09D Amgen En-
Apr 30, 2024Exhibit Bp09C Amgen En-
Apr 30, 2024Exhibit Bp09B Amgen En-
Apr 30, 2024Exhibit Bp09 Amgen Grant History En-
Apr 30, 2024Exhibit Bp09A Amgen En-
Apr 30, 2024Exhibit Bp08 Amgen Table Grant Procedures En-
Apr 30, 2024Exhibit Bp07 Amgen En-
Apr 30, 2024Exhibit Bp06 Amgen En-
Apr 30, 2024Exhibit Bp05 Amgen En-
Apr 30, 2024Exhibit Bp04 Amgen Confidential En-
Apr 30, 2024Exhibit Bp03 Amgen Technical Background En-
Apr 30, 2024Exhibit Bp02 Amgen En-
Apr 30, 2024Exhibit Bp01 Amgen En-
Apr 30, 2024Exhibit Bp00 Amgen En Signed-
Apr 17, 2024Panel Appointment-
Apr 14, 2024Template Order-
Apr 14, 2024Procedural Order-
Apr 9, 2024Receipt-
Apr 9, 2024Notification Of Service-
Apr 9, 2024Mail Service Sweden-
Apr 9, 2024Antrag/Schriftsatz-
Apr 9, 2024Acknowledgement Of Access To Case-
Apr 2, 2024Acknowledgement Of Access To Case-
Mar 28, 2024Service Italy-
Mar 28, 2024Service Italien-
Mar 28, 2024Service French-
Mar 28, 2024Service Frankreich-
Mar 28, 2024Notification Of Service-
Mar 27, 2024Service Portugal-
Mar 27, 2024Service Munich-
Mar 27, 2024Service Belgium-
Mar 27, 2024Notification Of Service-
Mar 26, 2024Service Slovenia-
Mar 26, 2024Service Ireland-
Mar 26, 2024Service Austria-
Mar 26, 2024Panel Appointment-
Mar 26, 2024Notification Of Service-
Mar 20, 2024Receipt-
Mar 20, 2024Letter For Service-
Mar 20, 2024Invitation To Lodge
Mar 19, 2024Set Of Exhibits Fbd 5B-
Mar 19, 2024Set Of Exhibits Fbd 5A-
Mar 19, 2024Panel Appointment-
Mar 19, 2024Formal Checks Notification Of Positive Outcome-
Mar 19, 2024Exhibit Fbd 9-
Mar 19, 2024Exhibit Fbd 8-
Mar 19, 2024Exhibit Fbd 7-
Mar 19, 2024Exhibit Fbd 6-
Mar 19, 2024Exhibit Fbd 4-
Mar 19, 2024Exhibit Fbd 34-
Mar 19, 2024Exhibit Fbd 33A-
Mar 19, 2024Exhibit Fbd 33-
Mar 19, 2024Exhibit Fbd 32A-
Mar 19, 2024Exhibit Fbd 32-
Mar 19, 2024Exhibit Fbd 31-
Mar 19, 2024Exhibit Fbd 30-
Mar 19, 2024Exhibit Fbd 3-
Mar 19, 2024Exhibit Fbd 29-
Mar 19, 2024Exhibit Fbd 28-
Mar 19, 2024Exhibit Fbd 27-
Mar 19, 2024Exhibit Fbd 26-
Mar 19, 2024Exhibit Fbd 25-
Mar 19, 2024Exhibit Fbd 24-
Mar 19, 2024Exhibit Fbd 23-
Mar 19, 2024Exhibit Fbd 22-
Mar 19, 2024Exhibit Fbd 21-
Mar 19, 2024Exhibit Fbd 20-
Mar 19, 2024Exhibit Fbd 19-
Mar 19, 2024Exhibit Fbd 18A-
Mar 19, 2024Exhibit Fbd 18-
Mar 19, 2024Exhibit Fbd 17C-
Mar 19, 2024Exhibit Fbd 17B-
Mar 19, 2024Exhibit Fbd 17A-
Mar 19, 2024Exhibit Fbd 16-
Mar 19, 2024Exhibit Fbd 15-
Mar 19, 2024Exhibit Fbd 14-
Mar 19, 2024Exhibit Fbd 13-
Mar 19, 2024Exhibit Fbd 12-
Mar 19, 2024Exhibit Fbd 11-
Mar 19, 2024Exhibit Fbd 10-
Mar 19, 2024Exhibit Fbd 1-
Mar 19, 2024Exhibit Fbd 0-
Mar 19, 2024Confidential Exhibit Fbd 2-
Mar 19, 2024Application To Request Confidentiality From The Public-
Mar 19, 2024Application For Provisional Measures-
Mar 19, 2024Application For Measures Receipt-
Mar 19, 2024Application For Measures Acknowledgement-

More cases involving EP3167888B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
UPC_CFI_674/2025Jul 22, 2025Samsung Bioepis NLAlexion Pharmaceuticals
UPC_CFI_51/2025Jan 23, 2025Samsung Bioepis NLAlexion Pharmaceuticals
UPC_CFI_40/2025Jan 22, 2025Samsung Bioepis NLAlexion Pharmaceuticals

More cases involving Alexion Pharmaceuticals

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
App_35353/2025Aug 22, 2025Alexion Pharmaceuticals -
App_35118/2025Aug 20, 2025Alexion Pharmaceuticals -
App_35143/2025Aug 20, 2025Alexion Pharmaceuticals -

More cases involving Amgen Technology Ireland Unlimited

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
App_35200/2025Aug 21, 2025Amgen Technology Ireland Unlimited -
App_35086/2025Aug 20, 2025Amgen Technology Ireland Unlimited -
App_35087/2025Aug 20, 2025Amgen Technology Ireland Unlimited -